Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated by Analysts at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research report issued on Friday. The brokerage set a “sell” rating on the stock.

Separately, Craig Hallum raised Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.

Streamline Health Solutions Price Performance

STRM stock opened at $3.39 on Friday. The stock has a market capitalization of $14.32 million, a price-to-earnings ratio of -0.69 and a beta of 1.67. The firm’s 50-day moving average price is $2.76 and its two-hundred day moving average price is $5.11. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66. Streamline Health Solutions has a 12-month low of $1.85 and a 12-month high of $9.75.

Streamline Health Solutions (NASDAQ:STRM) last announced its quarterly earnings results on Monday, December 16th. The company reported ($0.61) earnings per share (EPS) for the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.